Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it—delivering the vaccine along with immune-stimulating molecules called cytokines—can…
Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it—delivering the vaccine along with immune-stimulating molecules called cytokines—can…
<iframe src="https://statesidedaily.com/embed/cluster/4dbfc98cd8d34cec7b6a1c9d7fb88efc064dcda7" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Amping up T cells to target cancer"></iframe>